June 14, 2016
RealTime Dynamix™: Bone and Mineral Metabolism, June 2016
Monthly refresh for the US phosphate binder and secondary hyperparathyroidism market wth launch metrics for Auryxia and Velphoro with pre-launch insight on Parsabiv, Amgen’s IV calcimimetic. n=104 nephrologists
About Spherix Global Insights
Spherix Global Insights is a newly established business intelligence and market research company headquartered in Cambridge, MA with EU offices in Zug, Switzerland. We specialize in renal, autoimmune, neurologic and rare disease markets.